Pharma & Healthcare
Global Nifedipine Controlled-release Tablets Market Research Report 2026
- Mar 17, 26
- ID: 736720
- Pages: 109
- Figures: 114
- Views: 7
This report delivers a comprehensive overview of the global Nifedipine Controlled-release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nifedipine Controlled-release Tablets. The Nifedipine Controlled-release Tablets market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nifedipine Controlled-release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nifedipine Controlled-release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bayer
Shanghai Shyndec Pharmaceutical
Beijing Honglin Pharma
Nanjing Easeheal Pharmaceutical
Qingdao BAHEAL Pharmaceutical
Simcere Pharmaceutical
Hefei Lifeon Pharmaceutical
China Resources Double-Crane Pharmaceutical
CSPC Ouyi Pharmaceutical
ApicHope Pharmaceutical
Segment by Type
Generic Drug
Original Drug
by Application
Hypertension
Coronary Heart Disease
Chronic Stable Angina
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nifedipine Controlled-release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Nifedipine Controlled-release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Nifedipine Controlled-release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nifedipine Controlled-release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bayer
Shanghai Shyndec Pharmaceutical
Beijing Honglin Pharma
Nanjing Easeheal Pharmaceutical
Qingdao BAHEAL Pharmaceutical
Simcere Pharmaceutical
Hefei Lifeon Pharmaceutical
China Resources Double-Crane Pharmaceutical
CSPC Ouyi Pharmaceutical
ApicHope Pharmaceutical
Segment by Type
Generic Drug
Original Drug
by Application
Hypertension
Coronary Heart Disease
Chronic Stable Angina
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nifedipine Controlled-release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Nifedipine Controlled-release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Nifedipine Controlled-release Tablets Market Overview
1.1 Product Definition
1.2 Nifedipine Controlled-release Tablets by Type
1.2.1 Global Nifedipine Controlled-release Tablets Market Value by Type: 2025 vs 2032
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Nifedipine Controlled-release Tablets by Application
1.3.1 Global Nifedipine Controlled-release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hypertension
1.3.3 Coronary Heart Disease
1.3.4 Chronic Stable Angina
1.3.5 Other
1.4 Global Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Controlled-release Tablets Revenue 2021–2032
1.4.2 Global Nifedipine Controlled-release Tablets Sales 2021–2032
1.4.3 Global Nifedipine Controlled-release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Nifedipine Controlled-release Tablets Market Competition by Manufacturers
2.1 Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nifedipine Controlled-release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Entry into the Industry
2.8 Global Nifedipine Controlled-release Tablets Market Competitive Situation and Trends
2.8.1 Global Nifedipine Controlled-release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nifedipine Controlled-release Tablets Players Market Share by Revenue
2.8.3 Global Nifedipine Controlled-release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Controlled-release Tablets Market Scenario by Region
3.1 Global Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2021–2032
3.2.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2021–2026
3.2.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2027–2032
3.3 Global Nifedipine Controlled-release Tablets Revenue by Region: 2021–2032
3.3.1 Global Nifedipine Controlled-release Tablets Revenue by Region: 2021–2026
3.3.2 Global Nifedipine Controlled-release Tablets Revenue by Region: 2027–2032
3.4 North America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.4.1 North America Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.4.3 North America Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.5.1 Europe Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.5.3 Europe Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Controlled-release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Controlled-release Tablets Sales by Type (2021–2032)
4.1.1 Global Nifedipine Controlled-release Tablets Sales by Type (2021–2026)
4.1.2 Global Nifedipine Controlled-release Tablets Sales by Type (2027–2032)
4.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2021–2032)
4.2.1 Global Nifedipine Controlled-release Tablets Revenue by Type (2021–2026)
4.2.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2027–2032)
4.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Nifedipine Controlled-release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nifedipine Controlled-release Tablets Sales by Application (2021–2032)
5.1.1 Global Nifedipine Controlled-release Tablets Sales by Application (2021–2026)
5.1.2 Global Nifedipine Controlled-release Tablets Sales by Application (2027–2032)
5.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2021–2032)
5.2.1 Global Nifedipine Controlled-release Tablets Revenue by Application (2021–2026)
5.2.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2027–2032)
5.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Nifedipine Controlled-release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Nifedipine Controlled-release Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Beijing Honglin Pharma
6.3.1 Beijing Honglin Pharma Company Information
6.3.2 Beijing Honglin Pharma Description and Business Overview
6.3.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio
6.3.5 Beijing Honglin Pharma Recent Developments/Updates
6.4 Nanjing Easeheal Pharmaceutical
6.4.1 Nanjing Easeheal Pharmaceutical Company Information
6.4.2 Nanjing Easeheal Pharmaceutical Description and Business Overview
6.4.3 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.4.5 Nanjing Easeheal Pharmaceutical Recent Developments/Updates
6.5 Qingdao BAHEAL Pharmaceutical
6.5.1 Qingdao BAHEAL Pharmaceutical Company Information
6.5.2 Qingdao BAHEAL Pharmaceutical Description and Business Overview
6.5.3 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.5.5 Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
6.6 Simcere Pharmaceutical
6.6.1 Simcere Pharmaceutical Company Information
6.6.2 Simcere Pharmaceutical Description and Business Overview
6.6.3 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.6.5 Simcere Pharmaceutical Recent Developments/Updates
6.7 Hefei Lifeon Pharmaceutical
6.7.1 Hefei Lifeon Pharmaceutical Company Information
6.7.2 Hefei Lifeon Pharmaceutical Description and Business Overview
6.7.3 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.7.5 Hefei Lifeon Pharmaceutical Recent Developments/Updates
6.8 China Resources Double-Crane Pharmaceutical
6.8.1 China Resources Double-Crane Pharmaceutical Company Information
6.8.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.8.3 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.9 CSPC Ouyi Pharmaceutical
6.9.1 CSPC Ouyi Pharmaceutical Company Information
6.9.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.9.3 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.9.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.10 ApicHope Pharmaceutical
6.10.1 ApicHope Pharmaceutical Company Information
6.10.2 ApicHope Pharmaceutical Description and Business Overview
6.10.3 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.10.5 ApicHope Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Controlled-release Tablets Industry Chain Analysis
7.2 Nifedipine Controlled-release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Controlled-release Tablets Production Mode & Process Analysis
7.4 Nifedipine Controlled-release Tablets Sales and Marketing
7.4.1 Nifedipine Controlled-release Tablets Sales Channels
7.4.2 Nifedipine Controlled-release Tablets Distributors
7.5 Nifedipine Controlled-release Tablets Customer Analysis
8 Nifedipine Controlled-release Tablets Market Dynamics
8.1 Nifedipine Controlled-release Tablets Industry Trends
8.2 Nifedipine Controlled-release Tablets Market Drivers
8.3 Nifedipine Controlled-release Tablets Market Challenges
8.4 Nifedipine Controlled-release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Nifedipine Controlled-release Tablets by Type
1.2.1 Global Nifedipine Controlled-release Tablets Market Value by Type: 2025 vs 2032
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Nifedipine Controlled-release Tablets by Application
1.3.1 Global Nifedipine Controlled-release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hypertension
1.3.3 Coronary Heart Disease
1.3.4 Chronic Stable Angina
1.3.5 Other
1.4 Global Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Controlled-release Tablets Revenue 2021–2032
1.4.2 Global Nifedipine Controlled-release Tablets Sales 2021–2032
1.4.3 Global Nifedipine Controlled-release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Nifedipine Controlled-release Tablets Market Competition by Manufacturers
2.1 Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nifedipine Controlled-release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Entry into the Industry
2.8 Global Nifedipine Controlled-release Tablets Market Competitive Situation and Trends
2.8.1 Global Nifedipine Controlled-release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nifedipine Controlled-release Tablets Players Market Share by Revenue
2.8.3 Global Nifedipine Controlled-release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Controlled-release Tablets Market Scenario by Region
3.1 Global Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2021–2032
3.2.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2021–2026
3.2.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2027–2032
3.3 Global Nifedipine Controlled-release Tablets Revenue by Region: 2021–2032
3.3.1 Global Nifedipine Controlled-release Tablets Revenue by Region: 2021–2026
3.3.2 Global Nifedipine Controlled-release Tablets Revenue by Region: 2027–2032
3.4 North America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.4.1 North America Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.4.3 North America Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.5.1 Europe Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.5.3 Europe Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Controlled-release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Controlled-release Tablets Sales by Type (2021–2032)
4.1.1 Global Nifedipine Controlled-release Tablets Sales by Type (2021–2026)
4.1.2 Global Nifedipine Controlled-release Tablets Sales by Type (2027–2032)
4.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2021–2032)
4.2.1 Global Nifedipine Controlled-release Tablets Revenue by Type (2021–2026)
4.2.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2027–2032)
4.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Nifedipine Controlled-release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nifedipine Controlled-release Tablets Sales by Application (2021–2032)
5.1.1 Global Nifedipine Controlled-release Tablets Sales by Application (2021–2026)
5.1.2 Global Nifedipine Controlled-release Tablets Sales by Application (2027–2032)
5.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2021–2032)
5.2.1 Global Nifedipine Controlled-release Tablets Revenue by Application (2021–2026)
5.2.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2027–2032)
5.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Nifedipine Controlled-release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Nifedipine Controlled-release Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Beijing Honglin Pharma
6.3.1 Beijing Honglin Pharma Company Information
6.3.2 Beijing Honglin Pharma Description and Business Overview
6.3.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio
6.3.5 Beijing Honglin Pharma Recent Developments/Updates
6.4 Nanjing Easeheal Pharmaceutical
6.4.1 Nanjing Easeheal Pharmaceutical Company Information
6.4.2 Nanjing Easeheal Pharmaceutical Description and Business Overview
6.4.3 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.4.5 Nanjing Easeheal Pharmaceutical Recent Developments/Updates
6.5 Qingdao BAHEAL Pharmaceutical
6.5.1 Qingdao BAHEAL Pharmaceutical Company Information
6.5.2 Qingdao BAHEAL Pharmaceutical Description and Business Overview
6.5.3 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.5.5 Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
6.6 Simcere Pharmaceutical
6.6.1 Simcere Pharmaceutical Company Information
6.6.2 Simcere Pharmaceutical Description and Business Overview
6.6.3 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.6.5 Simcere Pharmaceutical Recent Developments/Updates
6.7 Hefei Lifeon Pharmaceutical
6.7.1 Hefei Lifeon Pharmaceutical Company Information
6.7.2 Hefei Lifeon Pharmaceutical Description and Business Overview
6.7.3 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.7.5 Hefei Lifeon Pharmaceutical Recent Developments/Updates
6.8 China Resources Double-Crane Pharmaceutical
6.8.1 China Resources Double-Crane Pharmaceutical Company Information
6.8.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.8.3 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.9 CSPC Ouyi Pharmaceutical
6.9.1 CSPC Ouyi Pharmaceutical Company Information
6.9.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.9.3 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.9.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.10 ApicHope Pharmaceutical
6.10.1 ApicHope Pharmaceutical Company Information
6.10.2 ApicHope Pharmaceutical Description and Business Overview
6.10.3 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.10.5 ApicHope Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Controlled-release Tablets Industry Chain Analysis
7.2 Nifedipine Controlled-release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Controlled-release Tablets Production Mode & Process Analysis
7.4 Nifedipine Controlled-release Tablets Sales and Marketing
7.4.1 Nifedipine Controlled-release Tablets Sales Channels
7.4.2 Nifedipine Controlled-release Tablets Distributors
7.5 Nifedipine Controlled-release Tablets Customer Analysis
8 Nifedipine Controlled-release Tablets Market Dynamics
8.1 Nifedipine Controlled-release Tablets Industry Trends
8.2 Nifedipine Controlled-release Tablets Market Drivers
8.3 Nifedipine Controlled-release Tablets Market Challenges
8.4 Nifedipine Controlled-release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Nifedipine Controlled-release Tablets Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Nifedipine Controlled-release Tablets Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nifedipine Controlled-release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nifedipine Controlled-release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Nifedipine Controlled-release Tablets Sales by Region (kg), 2021–2026
Table 18. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Nifedipine Controlled-release Tablets Sales by Region (kg), 2027–2032
Table 20. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 27. North America Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 28. North America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 32. Europe Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 33. Europe Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 42. Latin America Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 43. Latin America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2021–2026)
Table 51. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2027–2032)
Table 52. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2021–2026)
Table 59. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2027–2032)
Table 60. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2021–2026)
Table 61. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2027–2032)
Table 62. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2021–2026)
Table 69. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Bayer Nifedipine Controlled-release Tablets Product
Table 74. Bayer Recent Developments/Updates
Table 75. Shanghai Shyndec Pharmaceutical Company Information
Table 76. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 77. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 79. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 80. Beijing Honglin Pharma Company Information
Table 81. Beijing Honglin Pharma Description and Business Overview
Table 82. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product
Table 84. Beijing Honglin Pharma Recent Developments/Updates
Table 85. Nanjing Easeheal Pharmaceutical Company Information
Table 86. Nanjing Easeheal Pharmaceutical Description and Business Overview
Table 87. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 89. Nanjing Easeheal Pharmaceutical Recent Developments/Updates
Table 90. Qingdao BAHEAL Pharmaceutical Company Information
Table 91. Qingdao BAHEAL Pharmaceutical Description and Business Overview
Table 92. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 94. Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
Table 95. Simcere Pharmaceutical Company Information
Table 96. Simcere Pharmaceutical Description and Business Overview
Table 97. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 99. Simcere Pharmaceutical Recent Developments/Updates
Table 100. Hefei Lifeon Pharmaceutical Company Information
Table 101. Hefei Lifeon Pharmaceutical Description and Business Overview
Table 102. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 104. Hefei Lifeon Pharmaceutical Recent Developments/Updates
Table 105. China Resources Double-Crane Pharmaceutical Company Information
Table 106. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 107. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 109. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 110. CSPC Ouyi Pharmaceutical Company Information
Table 111. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 112. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 114. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 115. ApicHope Pharmaceutical Company Information
Table 116. ApicHope Pharmaceutical Description and Business Overview
Table 117. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 119. ApicHope Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nifedipine Controlled-release Tablets Distributors List
Table 123. Nifedipine Controlled-release Tablets Customers List
Table 124. Nifedipine Controlled-release Tablets Market Trends
Table 125. Nifedipine Controlled-release Tablets Market Drivers
Table 126. Nifedipine Controlled-release Tablets Market Challenges
Table 127. Nifedipine Controlled-release Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nifedipine Controlled-release Tablets
Figure 2. Global Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Nifedipine Controlled-release Tablets Market Share by Type: 2025 & 2032
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Nifedipine Controlled-release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hypertension
Figure 9. Coronary Heart Disease
Figure 10. Chronic Stable Angina
Figure 11. Other
Figure 12. Global Nifedipine Controlled-release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Nifedipine Controlled-release Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Nifedipine Controlled-release Tablets Sales (kg), 2021–2032
Figure 15. Global Nifedipine Controlled-release Tablets Average Price (US$/g), 2021–2032
Figure 16. Nifedipine Controlled-release Tablets Report Years Considered
Figure 17. Nifedipine Controlled-release Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Nifedipine Controlled-release Tablets Players: Market Share by Revenue in Nifedipine Controlled-release Tablets in 2025
Figure 20. Nifedipine Controlled-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 55. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2021–2032)
Figure 56. Global Sales Market Share of Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2021–2032)
Figure 59. Nifedipine Controlled-release Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Nifedipine Controlled-release Tablets Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Nifedipine Controlled-release Tablets Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nifedipine Controlled-release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nifedipine Controlled-release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Nifedipine Controlled-release Tablets Sales by Region (kg), 2021–2026
Table 18. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Nifedipine Controlled-release Tablets Sales by Region (kg), 2027–2032
Table 20. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 27. North America Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 28. North America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 32. Europe Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 33. Europe Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 42. Latin America Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 43. Latin America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2021–2026)
Table 51. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2027–2032)
Table 52. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2021–2026)
Table 59. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2027–2032)
Table 60. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2021–2026)
Table 61. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2027–2032)
Table 62. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2021–2026)
Table 69. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Bayer Nifedipine Controlled-release Tablets Product
Table 74. Bayer Recent Developments/Updates
Table 75. Shanghai Shyndec Pharmaceutical Company Information
Table 76. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 77. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 79. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 80. Beijing Honglin Pharma Company Information
Table 81. Beijing Honglin Pharma Description and Business Overview
Table 82. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product
Table 84. Beijing Honglin Pharma Recent Developments/Updates
Table 85. Nanjing Easeheal Pharmaceutical Company Information
Table 86. Nanjing Easeheal Pharmaceutical Description and Business Overview
Table 87. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 89. Nanjing Easeheal Pharmaceutical Recent Developments/Updates
Table 90. Qingdao BAHEAL Pharmaceutical Company Information
Table 91. Qingdao BAHEAL Pharmaceutical Description and Business Overview
Table 92. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 94. Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
Table 95. Simcere Pharmaceutical Company Information
Table 96. Simcere Pharmaceutical Description and Business Overview
Table 97. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 99. Simcere Pharmaceutical Recent Developments/Updates
Table 100. Hefei Lifeon Pharmaceutical Company Information
Table 101. Hefei Lifeon Pharmaceutical Description and Business Overview
Table 102. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 104. Hefei Lifeon Pharmaceutical Recent Developments/Updates
Table 105. China Resources Double-Crane Pharmaceutical Company Information
Table 106. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 107. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 109. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 110. CSPC Ouyi Pharmaceutical Company Information
Table 111. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 112. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 114. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 115. ApicHope Pharmaceutical Company Information
Table 116. ApicHope Pharmaceutical Description and Business Overview
Table 117. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 119. ApicHope Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nifedipine Controlled-release Tablets Distributors List
Table 123. Nifedipine Controlled-release Tablets Customers List
Table 124. Nifedipine Controlled-release Tablets Market Trends
Table 125. Nifedipine Controlled-release Tablets Market Drivers
Table 126. Nifedipine Controlled-release Tablets Market Challenges
Table 127. Nifedipine Controlled-release Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nifedipine Controlled-release Tablets
Figure 2. Global Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Nifedipine Controlled-release Tablets Market Share by Type: 2025 & 2032
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Nifedipine Controlled-release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hypertension
Figure 9. Coronary Heart Disease
Figure 10. Chronic Stable Angina
Figure 11. Other
Figure 12. Global Nifedipine Controlled-release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Nifedipine Controlled-release Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Nifedipine Controlled-release Tablets Sales (kg), 2021–2032
Figure 15. Global Nifedipine Controlled-release Tablets Average Price (US$/g), 2021–2032
Figure 16. Nifedipine Controlled-release Tablets Report Years Considered
Figure 17. Nifedipine Controlled-release Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Nifedipine Controlled-release Tablets Players: Market Share by Revenue in Nifedipine Controlled-release Tablets in 2025
Figure 20. Nifedipine Controlled-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 55. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2021–2032)
Figure 56. Global Sales Market Share of Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2021–2032)
Figure 59. Nifedipine Controlled-release Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232